• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

LIPID METABOLIC PROCESS

Diabetes drugs for Alzheimer’s disease

September 5, 2018Metabolic Disorders, Nervous System Disorders, Vizit Graphs
Diabetes drugs for Alzheimer’s disease

Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s.

Vizit Graphs Tag Cloud

METFORMIN TNF RECEPTOR REMICADE IMMUNE RESPONSE CELL PROLIFERATION ALZHEIMER'S DISEASE PSEUDOMONAS AERUGINOSA CLOSTRIDIUM DIFFICILE ERBB-2 HELICOBACTER PYLORI INSULIN ESCHERICHIA COLI CELL DIVISION STREPTOCOCCUS PNEUMONIAE PORPHYROMONAS GINGIVALIS PARKINSON DISEASE IL6 RHEUMATOID ARTHRITIS STAPHYLOCOCCUS AUREUS NEURODEGENERATIVE DISORDERS DIABETES MELLITUS BREAST CANCER AGING CD4 AUTOPHAGY 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE FOXP3 LISTERIA MONOCYTOGENES CELL DEATH APOPTOTIC PROCESS IFNG IL17A CANDIDA ALBICANS DOXORUBICIN TP53 INFLAMMATION TH17 CELLS IL23A CANCER ANGIOGENESIS CTLA4 CASP3 CELL DIFFERENTIATION SOD1

© 2019 Biovista Vizit All Rights Reserved.